speb/financial-data huggingface dataset:
SURG cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 6279973.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1800718.00
SURG cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -283463.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -303291.00
SURG cash_flow (annual, 2025-12-31) — Change In Receivables: -1044953.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Receivables: 246060.00
SURG cash_flow (annual, 2025-12-31) — Change In Tax Payable: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 0.00
SURG cash_flow (annual, 2025-12-31) — Change In Working Capital: 6145283.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 3256578.00
SURG cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1044953.00
SURG cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 246060.00
SURG cash_flow (annual, 2025-12-31) — Changes In Cash: -10777178.00
SURG cash_flow (quarterly, 2025-12-31) — Changes In Cash: -501651.00
SURG balance_sheet (annual, 2025-12-31) — Common Stock: 21852.00
SURG balance_sheet (quarterly, 2025-12-31) — Common Stock: 21852.00
SURG balance_sheet (annual, 2025-12-31) — Common Stock Equity: -15347675.00
SURG balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -15347675.00
SURG cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1774636.00
SURG cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1125253.00
SURG cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
SURG income_statement (annual, 2025-12-31) — Cost Of Revenue: 67551811.00
SURG income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 18582433.00
SURG balance_sheet (annual, 2025-12-31) — Current Assets: 6979766.00
SURG balance_sheet (quarterly, 2025-12-31) — Current Assets: 6979766.00
SURG balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 219997.00
SURG balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 219997.00
SURG balance_sheet (annual, 2025-12-31) — Current Debt: 7633682.00
SURG balance_sheet (quarterly, 2025-12-31) — Current Debt: 7633682.00
SURG balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 7853679.00
SURG balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 7853679.00
SURG balance_sheet (annual, 2025-12-31) — Current Liabilities: 18190236.00
SURG balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 18190236.00
SURG balance_sheet (annual, 2025-12-31) — Current Notes Payable: 1834008.00
SURG balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 1834008.00
SURG cash_flow (annual, 2025-12-31) — Depreciation: 1111341.00
SURG cash_flow (quarterly, 2025-12-31) — Depreciation: 254790.00
SURG cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1111341.00
SURG cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 254790.00
SURG income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 859974.00
SURG income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 190291.00
SURG cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1111341.00
SURG cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 254790.00
SURG income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 859974.00
SURG income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 190291.00
SURG income_statement (annual, 2025-12-31) — Diluted Average Shares: 20085138.00
SURG income_statement (annual, 2025-12-31) — Diluted EPS: -1.80
SURG income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -36068870.00
SURG income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -13862120.00
SURG balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 117546.00
SURG balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 117546.00
SURG income_statement (annual, 2025-12-31) — EBIT: -34065773.00
SURG income_statement (quarterly, 2025-12-31) — EBIT: -12796275.00
SURG income_statement (annual, 2025-12-31) — EBITDA: -32954432.00
SURG income_statement (quarterly, 2025-12-31) — EBITDA: -12541485.00
SURG income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 0.00
SURG income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 0.00
SURG cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
SURG cash_flow (annual, 2025-12-31) — End Cash Position: 2013211.00
SURG cash_flow (quarterly, 2025-12-31) — End Cash Position: 2013211.00
SURG cash_flow (annual, 2025-12-31) — Financing Cash Flow: 10534564.00
SURG cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 3062696.00
SURG cash_flow (annual, 2025-12-31) — Free Cash Flow: -21311742.00
SURG cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -3564347.00
SURG income_statement (annual, 2025-12-31) — General And Administrative Expense: 18942476.00
SURG income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 6579644.00
SURG balance_sheet (annual, 2025-12-31) — Goodwill: 0.00
SURG balance_sheet (quarterly, 2025-12-31) — Goodwill: 0.00
SURG balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 819153.00
SURG balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 819153.00
SURG balance_sheet (annual, 2025-12-31) — Gross PPE: 1939227.00
SURG balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1939227.00
SURG income_statement (annual, 2025-12-31) — Gross Profit: -10588891.00
SURG income_statement (quarterly, 2025-12-31) — Gross Profit: -2395426.00
SURG income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 3300000.00
SURG income_statement (annual, 2025-12-31) — Insurance And Claims: 983093.00
SURG income_statement (quarterly, 2025-12-31) — Insurance And Claims: 155935.00
SURG income_statement (annual, 2025-12-31) — Interest Expense: 2003935.00
SURG income_statement (quarterly, 2025-12-31) — Interest Expense: 1066038.00
SURG income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2003935.00
SURG income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1066038.00
SURG income_statement (annual, 2025-12-31) — Interest Income: 63950.00
SURG income_statement (quarterly, 2025-12-31) — Interest Income: 37.00
SURG income_statement (annual, 2025-12-31) — Interest Income Non Operating: 63950.00
SURG income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 37.00
SURG cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 245855.00
SURG cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: -18655.00
SURG balance_sheet (annual, 2025-12-31) — Inventory: 339570.00
SURG balance_sheet (quarterly, 2025-12-31) — Inventory: 339570.00
SURG balance_sheet (annual, 2025-12-31) — Invested Capital: -2084799.00
SURG balance_sheet (quarterly, 2025-12-31) — Invested Capital: -2084799.00
SURG cash_flow (annual, 2025-12-31) — Investing Cash Flow: -18590.00
SURG cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 0.00
SURG cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 1774636.00
SURG cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1125253.00
SURG cash_flow (annual, 2025-12-31) — Issuance Of Debt: 15078811.00
SURG cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 6104113.00
SURG balance_sheet (annual, 2025-12-31) — Leases: 324901.00
SURG balance_sheet (quarterly, 2025-12-31) — Leases: 324901.00
SURG balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 99235.00
SURG balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 99235.00
SURG balance_sheet (annual, 2025-12-31) — Long Term Debt: 5629194.00
SURG balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 5629194.00
SURG balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5728429.00
SURG balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5728429.00
SURG cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 15078811.00
SURG cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 6104113.00
SURG cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -5587686.00
SURG cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -4096853.00
SURG balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1300916.00
SURG balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1300916.00
SURG balance_sheet (annual, 2025-12-31) — Minority Interest: -55144.00
SURG balance_sheet (quarterly, 2025-12-31) — Minority Interest: -55144.00
SURG income_statement (annual, 2025-12-31) — Minority Interests: 838.00
SURG income_statement (quarterly, 2025-12-31) — Minority Interests: 193.00
SURG cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
SURG cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 1774636.00
SURG cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 1125253.00
SURG balance_sheet (annual, 2025-12-31) — Net Debt: 11531476.00
SURG balance_sheet (quarterly, 2025-12-31) — Net Debt: 11531476.00
SURG income_statement (annual, 2025-12-31) — Net Income: -36068870.00
SURG income_statement (quarterly, 2025-12-31) — Net Income: -13862120.00
SURG income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -36068870.00
SURG income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -13862120.00
SURG income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -36069708.00
SURG income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -13862313.00
SURG income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -36068870.00
SURG income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -13862120.00
SURG income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -36068870.00
SURG income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -13862120.00
SURG cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -36069708.00
SURG cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -13862313.00
SURG income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -36069708.00
SURG income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -13862313.00
SURG income_statement (annual, 2025-12-31) — Net Interest Income: -1939985.00
SURG income_statement (quarterly, 2025-12-31) — Net Interest Income: -1066001.00
SURG cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
SURG cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 9491125.00
SURG cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 2007260.00
SURG cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 9491125.00
SURG cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 2007260.00
SURG income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1939985.00
SURG income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1066001.00
SURG cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -731197.00
SURG cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -69817.00
SURG balance_sheet (annual, 2025-12-31) — Net PPE: 716927.00
SURG balance_sheet (quarterly, 2025-12-31) — Net PPE: 716927.00
SURG cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -18590.00
SURG cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
SURG balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -16166828.00
SURG balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -16166828.00
SURG balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 0.00
SURG balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 0.00
SURG income_statement (annual, 2025-12-31) — Normalized EBITDA: -29477581.00
SURG income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -9064634.00
SURG income_statement (annual, 2025-12-31) — Normalized Income: -32592019.00
SURG income_statement (quarterly, 2025-12-31) — Normalized Income: -10385269.00
SURG cash_flow (annual, 2025-12-31) — Operating Cash Flow: -21293152.00
SURG cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -3564347.00
SURG income_statement (annual, 2025-12-31) — Operating Income: -30660012.00
SURG income_statement (quarterly, 2025-12-31) — Operating Income: -9319461.00
SURG income_statement (annual, 2025-12-31) — Operating Revenue: 56962920.00
SURG income_statement (quarterly, 2025-12-31) — Operating Revenue: 16187007.00
SURG balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 21151974.00
SURG balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 21151974.00
SURG balance_sheet (annual, 2025-12-31) — Other Current Assets: 581823.00
SURG balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 581823.00
SURG balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 5799674.00
SURG balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 5799674.00
SURG income_statement (annual, 2025-12-31) — Other Gand A: 9259273.00
SURG income_statement (quarterly, 2025-12-31) — Other Gand A: 3123167.00
SURG income_statement (annual, 2025-12-31) — Other Income Expense: -3469711.00
SURG income_statement (quarterly, 2025-12-31) — Other Income Expense: -3476851.00
SURG balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 819153.00
SURG balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 819153.00
SURG cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1401356.00
SURG cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1194147.00
SURG income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 7140.00
SURG income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 0.00
SURG balance_sheet (annual, 2025-12-31) — Other Properties: 313410.00
SURG balance_sheet (quarterly, 2025-12-31) — Other Properties: 313410.00
SURG balance_sheet (annual, 2025-12-31) — Payables: 10336557.00
SURG balance_sheet (quarterly, 2025-12-31) — Payables: 10336557.00
SURG balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 10336557.00
SURG balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 10336557.00
SURG income_statement (annual, 2025-12-31) — Pretax Income: -36069708.00
SURG income_statement (quarterly, 2025-12-31) — Pretax Income: -13862313.00
SURG cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
SURG balance_sheet (annual, 2025-12-31) — Properties: 0.00
SURG balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SURG income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 176851.00
SURG cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
SURG cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
SURG cash_flow (annual, 2025-12-31) — Purchase Of PPE: -18590.00
SURG cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
SURG balance_sheet (annual, 2025-12-31) — Receivables: 4045162.00
SURG balance_sheet (quarterly, 2025-12-31) — Receivables: 4045162.00
SURG income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 67300444.00
SURG income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 18517934.00
SURG income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1111341.00
SURG income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 254790.00
SURG cash_flow (annual, 2025-12-31) — Repayment Of Debt: -5587686.00
SURG cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -4096853.00
SURG cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
SURG balance_sheet (annual, 2025-12-31) — Restricted Cash: 281811.00
SURG balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 281811.00
SURG balance_sheet (annual, 2025-12-31) — Retained Earnings: -96984297.00
SURG balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -96984297.00
SURG income_statement (annual, 2025-12-31) — Salaries And Wages: 8700110.00
SURG income_statement (quarterly, 2025-12-31) — Salaries And Wages: 3300542.00
SURG cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
SURG income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 268671.00
SURG income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 154100.00
SURG income_statement (annual, 2025-12-31) — Selling General And Administration: 19211147.00
SURG income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6733744.00
SURG balance_sheet (annual, 2025-12-31) — Share Issued: 21847927.00
SURG balance_sheet (quarterly, 2025-12-31) — Share Issued: 21847927.00
SURG income_statement (annual, 2025-12-31) — Special Income Charges: -3476851.00
SURG income_statement (quarterly, 2025-12-31) — Special Income Charges: -3476851.00
SURG cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2641725.00
SURG cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2115600.00
SURG balance_sheet (annual, 2025-12-31) — Stockholders Equity: -15347675.00
SURG balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -15347675.00
SURG balance_sheet (annual, 2025-12-31) — Tangible Book Value: -16166828.00
SURG balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -16166828.00
SURG income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SURG income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SURG income_statement (annual, 2025-12-31) — Tax Provision: 0.00
SURG income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
SURG income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
SURG income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
SURG balance_sheet (annual, 2025-12-31) — Total Assets: 8515846.00
SURG balance_sheet (quarterly, 2025-12-31) — Total Assets: 8515846.00
SURG balance_sheet (annual, 2025-12-31) — Total Capitalization: -9718481.00
SURG balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -9718481.00
SURG balance_sheet (annual, 2025-12-31) — Total Debt: 13582108.00
SURG balance_sheet (quarterly, 2025-12-31) — Total Debt: 13582108.00
SURG balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -15402819.00
SURG balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -15402819.00
SURG income_statement (annual, 2025-12-31) — Total Expenses: 87622932.00
SURG income_statement (quarterly, 2025-12-31) — Total Expenses: 25506468.00
SURG balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 23918665.00
SURG balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 23918665.00
SURG balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1536080.00
SURG balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1536080.00
SURG balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5728429.00
SURG balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5728429.00
SURG income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -34136863.00
SURG income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -12796312.00
SURG income_statement (annual, 2025-12-31) — Total Unusual Items: -3476851.00
SURG income_statement (quarterly, 2025-12-31) — Total Unusual Items: -3476851.00
SURG income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3476851.00
SURG income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3476851.00
SURG balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 695953.00
SURG balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 695953.00
SURG balance_sheet (annual, 2025-12-31) — Treasury Stock: 1631966.00
SURG balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 1631966.00
SURG balance_sheet (annual, 2025-12-31) — Working Capital: -11210470.00
SURG balance_sheet (quarterly, 2025-12-31) — Working Capital: -11210470.00
SURG income_statement (annual, 2025-12-31) — Write Off: 176851.00
SURG income_statement (quarterly, 2026-03-31) — +Operating Expense: 3501917.00
SURG income_statement (quarterly, 2026-03-31) — +Total Revenue: 15983983.00
SURG balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 17514013.00
SURG balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5041837.00
SURG balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1249139.00
SURG balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 86829583.00
SURG balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
SURG cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 163377.00
SURG cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 163377.00
SURG income_statement (quarterly, 2026-03-31) — Basic Average Shares: 23703775.00
SURG income_statement (quarterly, 2026-03-31) — Basic EPS: -0.51
SURG cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 2013211.00
SURG balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 266318.00
SURG balance_sheet (quarterly, 2026-03-31) — Capital Stock: 24890.00
SURG balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1991166.00
SURG balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1991166.00
SURG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 4953749.00
SURG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 0.00
SURG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4550799.00
SURG cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 7336591.00
SURG cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -52914.00
SURG cash_flow (quarterly, 2026-03-31) — Change In Payable: 7336591.00
SURG cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 7336591.00
SURG cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 171081.00
SURG cash_flow (quarterly, 2026-03-31) — Change In Receivables: -996674.00
SURG cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 6458084.00
SURG cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -996674.00
SURG cash_flow (quarterly, 2026-03-31) — Changes In Cash: 402950.00
SURG balance_sheet (quarterly, 2026-03-31) — Common Stock: 24890.00
SURG balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -23812673.00
SURG cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 2514375.00
SURG cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
SURG income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 23681432.00
SURG balance_sheet (quarterly, 2026-03-31) — Current Assets: 8208310.00
SURG balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 226225.00
SURG balance_sheet (quarterly, 2026-03-31) — Current Debt: 11958473.00
SURG balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 12184698.00
SURG balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 30042829.00
SURG balance_sheet (quarterly, 2026-03-31) — Current Notes Payable: 4214131.00
SURG cash_flow (quarterly, 2026-03-31) — Depreciation: 79555.00
SURG cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 242932.00
SURG income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 190291.00
SURG cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 242932.00
SURG income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 190291.00
SURG income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 23703775.00
SURG income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.51
SURG income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -12050883.00
SURG balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 159135.00
SURG income_statement (quarterly, 2026-03-31) — EBIT: -11169126.00
SURG income_statement (quarterly, 2026-03-31) — EBITDA: -10926194.00
SURG cash_flow (quarterly, 2026-03-31) — End Cash Position: 2416161.00
SURG cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 4953749.00
SURG cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4550799.00
SURG cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -30241.00
SURG income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 30241.00
SURG income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 3281704.00
SURG balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 655776.00
SURG balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 5041837.00
SURG balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1886511.00
SURG income_statement (quarterly, 2026-03-31) — Gross Profit: -7697449.00
SURG cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
SURG income_statement (quarterly, 2026-03-31) — Insurance And Claims: 258616.00
SURG income_statement (quarterly, 2026-03-31) — Interest Expense: 881908.00
SURG income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 881908.00
SURG income_statement (quarterly, 2026-03-31) — Interest Income: 0.00
SURG income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 0.00
SURG cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 38472.00
SURG balance_sheet (quarterly, 2026-03-31) — Inventory: 339570.00
SURG balance_sheet (quarterly, 2026-03-31) — Invested Capital: -8567696.00
SURG cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
SURG cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 2514375.00
SURG cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 3179272.00
SURG balance_sheet (quarterly, 2026-03-31) — Leases: 324901.00
SURG balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 40093.00
SURG balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3286504.00
SURG balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3326597.00
SURG cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 3179272.00
SURG cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -350398.00
SURG balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 1300916.00
SURG balance_sheet (quarterly, 2026-03-31) — Minority Interest: -55295.00
SURG income_statement (quarterly, 2026-03-31) — Minority Interests: 151.00
SURG cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 2514375.00
SURG balance_sheet (quarterly, 2026-03-31) — Net Debt: 13253811.00
SURG income_statement (quarterly, 2026-03-31) — Net Income: -12050883.00
SURG income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -12050883.00
SURG income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -12051034.00
SURG income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -12050883.00
SURG income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -12050883.00
SURG cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -12051034.00
SURG income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -12051034.00
SURG income_statement (quarterly, 2026-03-31) — Net Interest Income: -881908.00
SURG cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 2828874.00
SURG cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 2828874.00
SURG income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -881908.00
SURG cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -389500.00
SURG balance_sheet (quarterly, 2026-03-31) — Net PPE: 637372.00
SURG cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 0.00
SURG balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -24468449.00
SURG income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -10956435.00
SURG income_statement (quarterly, 2026-03-31) — Normalized Income: -12081124.00
SURG cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4550799.00
SURG cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -30241.00
SURG income_statement (quarterly, 2026-03-31) — Operating Income: -11199366.00
SURG income_statement (quarterly, 2026-03-31) — Operating Revenue: 15983983.00
SURG balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 24190822.00
SURG balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 410742.00
SURG balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 7744342.00
SURG balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 184983.00
SURG income_statement (quarterly, 2026-03-31) — Other Gand A: 1222039.00
SURG income_statement (quarterly, 2026-03-31) — Other Income Expense: 30241.00
SURG balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 655776.00
SURG cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 771778.00
SURG balance_sheet (quarterly, 2026-03-31) — Other Properties: 260694.00
SURG balance_sheet (quarterly, 2026-03-31) — Payables: 17673148.00
SURG balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 17673148.00
SURG income_statement (quarterly, 2026-03-31) — Pretax Income: -12051034.00
SURG balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
SURG cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
SURG balance_sheet (quarterly, 2026-03-31) — Receivables: 5041837.00
SURG income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 23628791.00
SURG income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 242932.00
SURG cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -350398.00
SURG cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
SURG balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 424995.00
SURG balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -109035180.00
SURG income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1801049.00
SURG income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 29922.00
SURG income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3311626.00
SURG balance_sheet (quarterly, 2026-03-31) — Share Issued: 24886775.00
SURG cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 57682.00
SURG balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -23812673.00
SURG balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -24468449.00
SURG income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SURG income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
SURG income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
SURG balance_sheet (quarterly, 2026-03-31) — Total Assets: 9501458.00
SURG balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -20526169.00
SURG balance_sheet (quarterly, 2026-03-31) — Total Debt: 15511295.00
SURG balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -23867968.00
SURG income_statement (quarterly, 2026-03-31) — Total Expenses: 27183349.00
SURG balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 33369426.00
SURG balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1293148.00
SURG balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3326597.00
SURG income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -11199367.00
SURG income_statement (quarterly, 2026-03-31) — Total Unusual Items: 30241.00
SURG income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 30241.00
SURG balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 695953.00
SURG balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 1631966.00
SURG balance_sheet (quarterly, 2026-03-31) — Working Capital: -21834519.00
SURG.V income_statement (annual, 2022-03-31) — +Operating Expense: 3722741.00
SURG.V income_statement (annual, 2022-03-31) — +Total Revenue: 0.00
SURG.V balance_sheet (annual, 2022-03-31) — Accounts Payable: 140184.00
SURG.V balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -360480.00
SURG.V balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 10653118.00
SURG.V cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 48792.00
SURG.V cash_flow (annual, 2022-03-31) — Amortization Of Intangibles: 48792.00
SURG.V income_statement (annual, 2022-03-31) — Basic Average Shares: 158930503.00
SURG.V income_statement (annual, 2022-03-31) — Basic EPS: -0.03
SURG.V cash_flow (annual, 2022-03-31) — Beginning Cash Position: 3274777.00
SURG.V balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 300888.00
SURG.V cash_flow (annual, 2022-03-31) — Capital Expenditure: -38140.00
SURG.V balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 126113.00
SURG.V balance_sheet (annual, 2022-03-31) — Capital Stock: 60131106.00
SURG.V balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 7822852.00
SURG.V balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 7822852.00
SURG.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: 13946360.00
SURG.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: -7835599.00
SURG.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Operating Activities: -1562686.00
SURG.V cash_flow (annual, 2022-03-31) — Change In Payable: 6811.00
SURG.V cash_flow (annual, 2022-03-31) — Change In Payables And Accrued Expense: 6811.00
SURG.V cash_flow (annual, 2022-03-31) — Change In Prepaid Assets: 50055.00
SURG.V cash_flow (annual, 2022-03-31) — Change In Receivables: -207440.00
SURG.V cash_flow (annual, 2022-03-31) — Change In Working Capital: -150574.00
SURG.V cash_flow (annual, 2022-03-31) — Changes In Cash: 4548075.00
SURG.V balance_sheet (annual, 2022-03-31) — Common Stock: 60131106.00
SURG.V balance_sheet (annual, 2022-03-31) — Common Stock Equity: 41534519.00
SURG.V cash_flow (annual, 2022-03-31) — Common Stock Issuance: 15050346.00
SURG.V income_statement (annual, 2022-03-31) — Cost Of Revenue: 48792.00
SURG.V balance_sheet (annual, 2022-03-31) — Current Accrued Expenses: 18000.00
SURG.V balance_sheet (annual, 2022-03-31) — Current Assets: 8252865.00
SURG.V balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 21080.00
SURG.V balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 21080.00
SURG.V balance_sheet (annual, 2022-03-31) — Current Liabilities: 1567013.00
SURG.V cash_flow (annual, 2022-03-31) — Deferred Income Tax: 2560000.00
SURG.V cash_flow (annual, 2022-03-31) — Deferred Tax: 2560000.00
SURG.V cash_flow (annual, 2022-03-31) — Depreciation: 48792.00
SURG.V cash_flow (annual, 2022-03-31) — Depreciation Amortization Depletion: 48792.00
SURG.V cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 48792.00
SURG.V income_statement (annual, 2022-03-31) — Diluted Average Shares: 158930503.00
SURG.V income_statement (annual, 2022-03-31) — Diluted EPS: -0.03
SURG.V income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -4889505.00
SURG.V balance_sheet (annual, 2022-03-31) — Dueto Related Parties Current: 11550.00
SURG.V income_statement (annual, 2022-03-31) — EBIT: -2321799.00
SURG.V income_statement (annual, 2022-03-31) — EBITDA: -2273007.00
SURG.V cash_flow (annual, 2022-03-31) — End Cash Position: 7822852.00
SURG.V cash_flow (annual, 2022-03-31) — Financing Cash Flow: 13946360.00
SURG.V cash_flow (annual, 2022-03-31) — Free Cash Flow: -1600826.00
SURG.V income_statement (annual, 2022-03-31) — General And Administrative Expense: 3311691.00
SURG.V balance_sheet (annual, 2022-03-31) — Gross PPE: 39388180.00
SURG.V income_statement (annual, 2022-03-31) — Gross Profit: -48792.00
SURG.V income_statement (annual, 2022-03-31) — Interest Expense: 7706.00
SURG.V income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 7706.00
SURG.V balance_sheet (annual, 2022-03-31) — Invested Capital: 41534519.00
SURG.V cash_flow (annual, 2022-03-31) — Investing Cash Flow: -7835599.00
SURG.V cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 15050346.00
SURG.V balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 105033.00
SURG.V balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 105033.00
SURG.V cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -34715.00
SURG.V balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 194651.00
SURG.V cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 15050346.00
SURG.V income_statement (annual, 2022-03-31) — Net Income: -4889505.00
SURG.V income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -4889505.00
SURG.V income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -4889505.00
SURG.V income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -4889505.00
SURG.V income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -4889505.00
SURG.V cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -4889505.00
SURG.V income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -4889505.00
SURG.V income_statement (annual, 2022-03-31) — Net Interest Income: -7706.00
SURG.V cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -34715.00
SURG.V cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -34715.00
SURG.V income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -7706.00
SURG.V cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -1069271.00
SURG.V cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -7797459.00
SURG.V balance_sheet (annual, 2022-03-31) — Net PPE: 39027700.00
SURG.V cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -38140.00
SURG.V balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 41534519.00
SURG.V balance_sheet (annual, 2022-03-31) — Non Current Deferred Liabilities: 4074000.00
SURG.V balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 4074000.00
SURG.V income_statement (annual, 2022-03-31) — Normalized EBITDA: -2273007.00
SURG.V income_statement (annual, 2022-03-31) — Normalized Income: -4889505.00
SURG.V cash_flow (annual, 2022-03-31) — Operating Cash Flow: -1562686.00
SURG.V income_statement (annual, 2022-03-31) — Operating Income: -3771533.00
SURG.V income_statement (annual, 2022-03-31) — Operating Revenue: 0.00
SURG.V balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 166966470.00
SURG.V balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 1376199.00
SURG.V income_statement (annual, 2022-03-31) — Other Gand A: 1023889.00
SURG.V income_statement (annual, 2022-03-31) — Other Income Expense: 1449734.00
SURG.V cash_flow (annual, 2022-03-31) — Other Non Cash Items: -1419201.00
SURG.V income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 1449734.00
SURG.V income_statement (annual, 2022-03-31) — Other Operating Expenses: 185330.00
SURG.V balance_sheet (annual, 2022-03-31) — Other Properties: 38892641.00
SURG.V balance_sheet (annual, 2022-03-31) — Other Receivables: 32470.00
SURG.V income_statement (annual, 2022-03-31) — Other Taxes: 0.00
SURG.V balance_sheet (annual, 2022-03-31) — Payables: 151734.00
SURG.V balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 169734.00
SURG.V balance_sheet (annual, 2022-03-31) — Prepaid Assets: 85120.00
SURG.V income_statement (annual, 2022-03-31) — Pretax Income: -2329505.00
SURG.V cash_flow (annual, 2022-03-31) — Purchase Of PPE: -38140.00
SURG.V balance_sheet (annual, 2022-03-31) — Receivables: 344893.00
SURG.V income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 48792.00
SURG.V income_statement (annual, 2022-03-31) — Reconciled Depreciation: 48792.00
SURG.V cash_flow (annual, 2022-03-31) — Repayment Of Debt: -34715.00
SURG.V balance_sheet (annual, 2022-03-31) — Retained Earnings: -29249705.00
SURG.V income_statement (annual, 2022-03-31) — Salaries And Wages: 2287802.00
SURG.V income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 225720.00
SURG.V income_statement (annual, 2022-03-31) — Selling General And Administration: 3537411.00
SURG.V balance_sheet (annual, 2022-03-31) — Share Issued: 166966470.00
SURG.V cash_flow (annual, 2022-03-31) — Stock Based Compensation: 2287802.00
SURG.V balance_sheet (annual, 2022-03-31) — Stockholders Equity: 41534519.00
SURG.V balance_sheet (annual, 2022-03-31) — Tangible Book Value: 41534519.00
SURG.V income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
SURG.V income_statement (annual, 2022-03-31) — Tax Provision: 2560000.00
SURG.V income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.26
SURG.V balance_sheet (annual, 2022-03-31) — Taxes Receivable: 312423.00
SURG.V balance_sheet (annual, 2022-03-31) — Total Assets: 47280565.00
SURG.V balance_sheet (annual, 2022-03-31) — Total Capitalization: 41534519.00
SURG.V balance_sheet (annual, 2022-03-31) — Total Debt: 126113.00
SURG.V balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 41534519.00
SURG.V income_statement (annual, 2022-03-31) — Total Expenses: 3771533.00
SURG.V balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 5746046.00
SURG.V balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 39027700.00
SURG.V balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 4179033.00
SURG.V balance_sheet (annual, 2022-03-31) — Working Capital: 6685852.00
SURG.V income_statement (annual, 2023-03-31) — +Operating Expense: 3315134.00
SURG.V income_statement (annual, 2023-03-31) — +Total Revenue: 0.00
SURG.V balance_sheet (annual, 2023-03-31) — Accounts Payable: 71703.00
SURG.V balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -372691.00
SURG.V balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 12211778.00
SURG.V cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 39333.00
SURG.V cash_flow (annual, 2023-03-31) — Amortization Of Intangibles: 39333.00
SURG.V income_statement (annual, 2023-03-31) — Basic Average Shares: 173432433.00
SURG.V income_statement (annual, 2023-03-31) — Basic EPS: -0.01
SURG.V cash_flow (annual, 2023-03-31) — Beginning Cash Position: 7822852.00
SURG.V balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 273766.00
SURG.V cash_flow (annual, 2023-03-31) — Capital Expenditure: -3354.00
SURG.V balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 105033.00
SURG.V balance_sheet (annual, 2023-03-31) — Capital Stock: 63850642.00
SURG.V balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 2821995.00
SURG.V balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2821995.00
SURG.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 4117926.00
SURG.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -8247423.00
SURG.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -871360.00
SURG.V cash_flow (annual, 2023-03-31) — Change In Payable: 198560.00
SURG.V cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: 198560.00
SURG.V cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: -22629.00
SURG.V cash_flow (annual, 2023-03-31) — Change In Receivables: 305248.00
SURG.V cash_flow (annual, 2023-03-31) — Change In Working Capital: 481179.00
SURG.V cash_flow (annual, 2023-03-31) — Changes In Cash: -5000857.00
SURG.V balance_sheet (annual, 2023-03-31) — Common Stock: 63850642.00
SURG.V balance_sheet (annual, 2023-03-31) — Common Stock Equity: 44700301.00
SURG.V cash_flow (annual, 2023-03-31) — Common Stock Issuance: 4208051.00
SURG.V income_statement (annual, 2023-03-31) — Cost Of Revenue: 39333.00
SURG.V balance_sheet (annual, 2023-03-31) — Current Accrued Expenses: 26000.00
SURG.V balance_sheet (annual, 2023-03-31) — Current Assets: 2969389.00
SURG.V balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 24666.00
SURG.V balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 24666.00
SURG.V balance_sheet (annual, 2023-03-31) — Current Liabilities: 1249842.00
SURG.V cash_flow (annual, 2023-03-31) — Deferred Income Tax: 246000.00
SURG.V cash_flow (annual, 2023-03-31) — Deferred Tax: 246000.00
SURG.V cash_flow (annual, 2023-03-31) — Depreciation: 39333.00
SURG.V cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 39333.00
SURG.V cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 39333.00
SURG.V income_statement (annual, 2023-03-31) — Diluted Average Shares: 173432433.00
SURG.V income_statement (annual, 2023-03-31) — Diluted EPS: -0.01
SURG.V income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -2112414.00
SURG.V balance_sheet (annual, 2023-03-31) — Dueto Related Parties Current: 215922.00
SURG.V income_statement (annual, 2023-03-31) — EBIT: -1853425.00
SURG.V income_statement (annual, 2023-03-31) — EBITDA: -1814092.00
SURG.V cash_flow (annual, 2023-03-31) — End Cash Position: 2821995.00
SURG.V cash_flow (annual, 2023-03-31) — Financing Cash Flow: 4117926.00
SURG.V cash_flow (annual, 2023-03-31) — Free Cash Flow: -874714.00
SURG.V income_statement (annual, 2023-03-31) — General And Administrative Expense: 2990113.00
SURG.V balance_sheet (annual, 2023-03-31) — Gross PPE: 47753812.00
SURG.V income_statement (annual, 2023-03-31) — Gross Profit: -39333.00
SURG.V income_statement (annual, 2023-03-31) — Interest Expense: 12989.00
SURG.V income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 12989.00
SURG.V income_statement (annual, 2023-03-31) — Interest Income: 67249.00
SURG.V income_statement (annual, 2023-03-31) — Interest Income Non Operating: 67249.00
SURG.V balance_sheet (annual, 2023-03-31) — Invested Capital: 44700301.00
SURG.V cash_flow (annual, 2023-03-31) — Investing Cash Flow: -8247423.00
SURG.V cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 4208051.00
SURG.V balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 80367.00
SURG.V balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 80367.00
SURG.V cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -21080.00
SURG.V balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 194651.00
SURG.V cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 4208051.00
SURG.V income_statement (annual, 2023-03-31) — Net Income: -2112414.00
SURG.V income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -2112414.00
SURG.V income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -2112414.00
SURG.V income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -2112414.00
SURG.V income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -2112414.00
SURG.V cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -2112414.00
SURG.V income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -2112414.00
SURG.V income_statement (annual, 2023-03-31) — Net Interest Income: 54260.00
SURG.V cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -21080.00
SURG.V cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -21080.00
SURG.V income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 54260.00
SURG.V cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -69045.00
SURG.V cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -8244069.00
SURG.V balance_sheet (annual, 2023-03-31) — Net PPE: 47381121.00